Novodiag® Launch, a New Diagnostic Solution for Infectious Diseases
Mobidiag, a Finnish molecular diagnostics company, launches Novodiag ® , a fully automated solution for syndromic and targeted testing of infectious diseases, supporting limitation of antibiotic use.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180102005521/en/
The end of 2017 has been marked by a key event for Mobidiag, the launch of the Novodiag® solution at the Finnish Embassy in Paris (France) with the support of M. Ambroise Fayolle, VP of the EIB (European Investment Bank) and Dr. Etienne Ruppé, MCU-PH/Associate Professor, bacteriology department at Bichat hospital (Paris, France).
The new Novodiag® solution allows direct analysis of a patient sample placed in a disposable cartridge and delivers comprehensive results within a few hours. In a time where antibiotic resistance is a major threat for global health, the optimized process offered by Novodiag allows, among other things, to detect antibiotic resistance and limit the systematic use of antibiotics. This instrument allows detection of infectious diseases in a few hours and supports infection management accordingly.
This molecular diagnostic solution offers an easy to use and cost-efficient method, with very limited hands-on-time and without the need for much technical expertise. Novodiag is particularly suitable for low volumes and on demand testing for clinical laboratories.
Novodiag brings the power of molecular diagnostics into routine use for on-demand targeted and syndromic testing, a combination unachieved by other providers says Tuomas Tenkanen, CEO at Mobidiag.
One of our cartridges can also identify dozens of targets, including the majority of bacteria that cause diarrhea, for instance. With quick and reliable results, our fully automated system can support early decision making prior to any treatment delivery and also improve patient care by reducing for example the unnecessary use of antibiotics, a key focus in our product pipeline explains Tuomas Tenkanen.
Zoom on Mobidiag, a committed player in the fight against antibiotic
Mobidiag takes action in infectious disease diagnostics, including antibiotic resistances. There are between twenty five to thirty antibiotic resistant genes. Our solution can, with one single sample, detect large panel of targets. We can then avoid spreading of these resistances in hospital settings , sates Yann Marcy, Director of Mobidiag France.
Learn more about Novodiag .
About Mobidiag Ltd.
Established in 2000, Mobidiag develops and commercializes innovative solutions to advance the diagnosis of infectious diseases and serves the European clinical diagnostics market since 2008. Mobidiag is headquartered in Espoo, Finland, with an R&D center in France and subsidiaries in UK and Sweden.
Combining Amplidiag and Novodiag solutions, Mobidiag offers a comprehensive line of products for fast, reliable and cost-efficient diagnostics. Mobidiag is then able to cover all laboratories requirements no matter their size, throughput and centralized/decentralized organization.
To learn more, visit www.mobidiag.com .
Dorothee Allard, + 33(0)1 55 25 17 13
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
KOZA-ALTIN13.7.2018 18:00 | pressemeddelelse
Koza Altin Welcomes Court’s Rejection of Akin Ipek’s Share Purchase Agreement
MINDBREEZE13.7.2018 17:29 | pressemeddelelse
Mindbreeze Positioned in the Leaders Quadrant of the Gartner’s 2018 Magic Quadrant for Insight Engines
H.I.G.-CAPITAL13.7.2018 16:08 | pressemeddelelse
H.I.G. Capital Announces the Sale of Kondor
VISA-INC.13.7.2018 11:02 | pressemeddelelse
Contactless Technology Powers Fifty Percent of Purchases at 2018 FIFA World Cup Russia™
FL-AERSALE12.7.2018 21:20 | pressemeddelelse
Brazil Approves AerSafe for Airbus 321 Aircraft to Comply with Fuel Tank Flammability Reduction Rule
NJ-ADENTS12.7.2018 20:22 | pressemeddelelse
Blockchain-based Adents NovaTrack Issues Token to Standardize Access to Comprehensive Supply Chain Traceability
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum